◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Xtrackers FTSE 100 Short Daily Swap UCITS ETF 1C (XUKS) ETF Overview

Name: Xtrackers FTSE 100 Short Daily Swap UCITS ETF 1C (XUKS) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-01

Xtrackers FTSE 100 Short Daily Swap UCITS ETF 1C (XUKS) is an exchange-traded fund managed by DWS Investment S.A. (ETF). It manages roughly £7 million in assets.

Interactive chart & fund stats →

XUKS Fund Statistics

Expense ratio	0.50%
Trailing yield	0.00%
Assets under management	£7 million
Fund family	DWS Investment S.A. (ETF)
Inception	2008-06-02

The live price chart, fund profile and news are in the interactive XUKS viewer.

Other Companies in —

GBBD · Amundi Core GBP Corporate Bond UCITS ETF Dist — £7 million
DDOC · Global X Telemedicine & Digital Health ETF A — €7 million
EDOC · Global X Telemedicine & Digital Health ETF A — $7 million
XNNV · Xtrackers MSCI Innovation UCITS ETF 1C USD Acc — $7 million
SC0R · Invesco STOXX Europe 600 Optimised Travel & Leisure UCITS ETF — €7 million
FGPT · First Trust Bloomberg Artificial Intelligence UCITS ETF Class A Acc — £7 million
ASWG · Future of Defence Screened UCITS ETF USD Acc — €7 million
NAT8 · Future of Defence Screened UCITS ETF USD Acc — £7 million

← XUIN All “X” companies XUKX →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.